Glenmark Pharma’s arm recalls ‘Tacrolimus Ointment’ in US markets

16 Aug 2022 Evaluate

Glenmark Pharmaceuticals’ New Jersey-based subsidiary -- Glenmark Pharmaceuticals Inc, is recalling over 6.5 lakh tubes of a generic skin treatment ointment ‘Tacrolimus Ointment’ in US markets which is used to treat eczema. The recall is due to ‘Defective Container’. The company initiated the nationwide Class III recall on July 11 this year. The affected lot has been manufactured in India and distributed in the US by Glenmark Pharmaceuticals Inc.

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.

Glenmark Pharma Share Price

2166.65 -2.45 (-0.11%)
10-Apr-2026 13:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1651.40
Dr. Reddys Lab 1227.50
Cipla 1235.10
Zydus Lifesciences 914.60
Lupin 2328.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×